[HTML][HTML] Novel advances in inhibiting advanced glycation end product formation using natural compounds
Q Song, J Liu, L Dong, X Wang, X Zhang - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Advanced glycation end products (AGEs) are a group of complex compounds generated by
nonenzymatic interactions between proteins and reducing sugars or lipids. AGEs …
nonenzymatic interactions between proteins and reducing sugars or lipids. AGEs …
Targeting aging mechanisms: pharmacological perspectives
Geroprotectors slow down aging and promote healthy longevity in model animals. Although
hundreds of compounds have been shown to extend the life of laboratory model organisms …
hundreds of compounds have been shown to extend the life of laboratory model organisms …
Advanced glycation end products in health and disease
Advanced glycation end products (AGEs), formed through the nonenzymatic reaction of
reducing sugars with the side-chain amino groups of lysine or arginine of proteins, followed …
reducing sugars with the side-chain amino groups of lysine or arginine of proteins, followed …
[HTML][HTML] Physiology and pathophysiology of carnosine
Abstract Carnosine (β-alanyl-l-histidine) was discovered in 1900 as an abundant non-
protein nitrogen-containing compound of meat. The dipeptide is not only found in skeletal …
protein nitrogen-containing compound of meat. The dipeptide is not only found in skeletal …
Baking, ageing, diabetes: a short history of the Maillard reaction
The reaction of reducing carbohydrates with amino compounds described in 1912 by Louis‐
Camille Maillard is responsible for the aroma, taste, and appearance of thermally processed …
Camille Maillard is responsible for the aroma, taste, and appearance of thermally processed …
[HTML][HTML] Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure
Introduction There is epidemiological evidence that metal contaminants may play a role in
the development of atherosclerosis and its complications. Moreover, a recent clinical trial of …
the development of atherosclerosis and its complications. Moreover, a recent clinical trial of …
Uremic toxicity of advanced glycation end products in CKD
Advanced glycation end products (AGEs), a heterogeneous group of compounds formed by
nonenzymatic glycation reactions between reducing sugars and amino acids, lipids, or DNA …
nonenzymatic glycation reactions between reducing sugars and amino acids, lipids, or DNA …
Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention
Advanced glycation end-products (AGEs) are non-enzymatic protein and amino acid
adducts as well as DNA adducts which form from dicarbonyls and glucose. AGE formation is …
adducts as well as DNA adducts which form from dicarbonyls and glucose. AGE formation is …
Advanced glycation end products: potential mechanism and therapeutic target in cardiovascular complications under diabetes
P Yang, J Feng, Q Peng, X Liu… - Oxidative Medicine and …, 2019 - Wiley Online Library
The occurrence and development of cardiovascular complications are predominantly
responsible for the increased morbidity and mortality observed in patients with diabetes …
responsible for the increased morbidity and mortality observed in patients with diabetes …
Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy
Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetic patients
and a leading cause of end-stage renal disease (ESRD). Degenerative changes such as …
and a leading cause of end-stage renal disease (ESRD). Degenerative changes such as …